Verona Pharma News

Verona Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 12 19:49 ET

Verona Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 4 20:16 ET

Verona Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 5 16:25 ET

Verona Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 3, 2023 16:25 ET

Verona Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 3, 2023 16:12 ET

Verona Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

May 11, 2023 18:18 ET

Verona Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

May 3, 2023 16:38 ET

Verona Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 9, 2023 18:58 ET

Verona Pharma | 424B5: Prospectus

Aug 11, 2022 17:09 ET

Verona Pharma | 424B5: Prospectus

Aug 9, 2022 16:53 ET

Verona Pharma | EFFECT: Others

Mar 30, 2021 00:15 ET

Verona Pharma | EFFECT: Others

Mar 26, 2021 00:15 ET

Verona Pharma | 424B3: Prospectus

Jan 4, 2021 16:46 ET

Verona Pharma | EFFECT: Others

Aug 28, 2020 00:15 ET

Verona Pharma | EFFECT: Others

Jun 5, 2018 00:15 ET

Verona Pharma | 424B4: Prospectus

Apr 27, 2017 21:51 ET

Verona Pharma | EFFECT: Others

Apr 27, 2017 00:15 ET

Verona Pharma | EFFECT: Others

Apr 27, 2017 00:15 ET

Verona Pharma | F-1MEF: A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form F-1

Apr 26, 2017 19:23 ET

Verona Pharma | 8-A12B: Registration of a class of securities on a national securities exchange

Apr 19, 2017 15:23 ET